Abstract:G protein-coupled receptors (GPCRs) mediate cellular responses to a myriad of hormones and neurotransmitters that play vital roles in the regulation of physiological processes such as blood pressure. In organs such as the artery and kidney, hormones or neurotransmitters, such as angiotensin II (Ang II), dopamine, epinephrine, and norepinephrine exert their functions via their receptors, with the ultimate effect of keeping normal vascular reactivity, normal body sodium, and normal blood pressure. GPCR kinases (GRKs) exert their biological functions, by mediating the regulation of agonist-occupied GPCRs, non-GPCRs, or non-receptor substrates. In particular, increasing number of studies show that aberrant expression and activity of GRKs in the cardiovascular system and kidney inhibit or stimulate GPCRs (e.g., dopamine receptors, Ang II receptors, and α- and β-adrenergic receptors), resulting in hypertension. Current studies focus on the effect of selective GRK inhibitors in cardiovascular diseases, including hypertension. Moreover, genetic studies show that GRK gene variants are associated with essential hypertension, blood pressure response to antihypertensive medicines, and adverse cardiovascular outcomes of antihypertensive treatment. In this review, we present a comprehensive overview of GRK-mediated regulation of blood pressure, role of GRKs in the pathogenesis of hypertension, and highlight potential strategies for the treatment of hypertension. Schematic representation of GPCR desensitization process. Activation of GPCRs begins with the binding of an agonist to its corresponding receptor. Then G proteins activate downstream effectors that are mediated by various signaling pathways. GPCR signaling is halted by GRK-mediated receptor phosphorylation, which causes receptor internalization through β-arrestin.

Recent Advances on the Role of G-protein-coupled Receptors in Kidney Diseases

G Protein and its signaling pathway in bone development and disease.

Role of G protein coupled receptors in acute kidney injury

G protein-coupled receptors: potential therapeutic targets for diabetic nephropathy.

The roles of G protein-coupled receptor kinase 2 in renal diseases

GPCRs involved in metabolic diseases: pharmacotherapeutic development updates

Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling

G protein-coupled receptor kinases in hypertension: physiology, pathogenesis, and therapeutic targets

Recent Developments in Parathyroid Hormone Type 1 Receptor and Kidney Disease

Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors

Toll-like Receptors as Potential Therapeutic Targets in Kidney Diseases

The Complement C3a and C3a Receptor Pathway in Kidney Diseases.

The Advancement of Pathway on G Protein-coupled Receptors(GPCRs) Target to Cancer

Structure, function and drug discovery of GPCR signaling

Role of G-protein coupled receptors in cardiovascular diseases

G Protein-Coupled Receptor Signaling: Transducers and Effectors

Molecular Targets and Therapeutic Potentials

Nuclear receptors in renal health and disease

Novel insights into NOD-like receptors in renal diseases

The Complement C3a and C3a Receptor Pathway in Kidney Diseases

Pathophysiological roles of G-protein-coupled receptor kinases